GURUFOCUS.COM » STOCK LIST » Real Estate » Real Estate » Rafael Holdings Inc (NYSE:RFL) » Definitions » 9-Day RSI

Rafael Holdings (Rafael Holdings) 9-Day RSI : 37.40 (As of May. 11, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Rafael Holdings 9-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.

As of today (2024-05-11), Rafael Holdings's 9-Day RSI is 37.40.

The industry rank for Rafael Holdings's 9-Day RSI or its related term are showing as below:

RFL's 9-Day RSI is ranked better than
82.45% of 1937 companies
in the Real Estate industry
Industry Median: 52.76 vs RFL: 37.40

Competitive Comparison of Rafael Holdings's 9-Day RSI

For the Real Estate Services subindustry, Rafael Holdings's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rafael Holdings's 9-Day RSI Distribution in the Real Estate Industry

For the Real Estate industry and Real Estate sector, Rafael Holdings's 9-Day RSI distribution charts can be found below:

* The bar in red indicates where Rafael Holdings's 9-Day RSI falls into.



Rafael Holdings  (NYSE:RFL) 9-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Rafael Holdings  (NYSE:RFL) 9-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.


Rafael Holdings 9-Day RSI Related Terms

Thank you for viewing the detailed overview of Rafael Holdings's 9-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


Rafael Holdings (Rafael Holdings) Business Description

Traded in Other Exchanges
N/A
Address
520 Broad Street, Newark, NJ, USA, 07102
Rafael Holdings Inc, through its subsidiaries, is a clinical stage, oncology-focused pharmaceutical company committed to the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company is a significant investor in two clinical stage oncology companies, Cornerstone Pharmaceuticals, Inc., and LipoMedix Pharmaceuticals Ltd.
Executives
I9 Plus, Llc 10 percent owner 153 BOOTH AVE, ENGLEWOOD NJ 07631
Howard S Jonas director
Mary Margaret Huizinga officer: Chief Devel. & Medical Officer C/O RAFAEL HOLDINGS, INC., 520 BROAD ST, NEWARK NJ 07102
Ashok D Marin officer: Chief Legal Officer C/O LIPOSCIENCE, INC., 2500 SUMNER BOULEVARD, RALEIGH NC 27616
Patrick Fabbio officer: Chief Financial Officer 2 PITNEY COURT, BASKING RIDGE NJ 07920
Mark Anthony Mccamish director C/O FORTY SEVEN, INC., 1490 O'BRIEN DRIVE, SUITE A, MENLO PARK CA 94025
Shannon Thyme Klinger director 200 TECHNOLOGY SQUARE, SUITE 300, CAMBRIDGE MA 02139
Ameet Mallik officer: CHIEF EXECUTIVE OFFICER C/O RAFAEL HOLDINGS, INC., 520 BROAD ST, NEWARK NJ 07102
William Conkling officer: Chief Commercial Officer C/O RAFAEL HOLDINGS, INC., 520 BROAD ST, NEWARK NJ 07102
Rachel Jonas director C/O RAFAEL HOLDINGS, INC., 520 BROAD ST, NEWARK NJ 07102
Boris C Pasche director C/O RAFAEL HOLDINGS, INC., 520 BROAD ST, NEWARK NJ 07102
Michael J Weiss director C/O NET2PHONE INC, 520 BROAD ST, NEWARK NJ 07102
Stephen M Greenberg director C/O NET2PHONE INC, 520 BROAD ST, NEWARK NJ 07102
David Polinsky officer: Chief Financial Officer 90 BOOTH AVENUE, ENGLEWOOD NJ 07631
Menachem Ash director, officer: President C/O IDT CORPORATION, 520 BROAD STREET, NEWARK NJ 07102

Rafael Holdings (Rafael Holdings) Headlines

From GuruFocus